跳至主要内容
临床试验/NCT04788368
NCT04788368已完成不适用

TRECA - TREatment of Colorectal Adenomas and Early Colorectal CAncer in Region Västra Götaland

Sahlgrenska University Hospital, Sweden1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Pathological clear margins

研究概览

简要总结

All early colorectal cancers (T1-T2) treated in the Region Västra Götaland from 2007-2020 will be evaluated. To establish the extent to which early colorectal cancers have been treated with local excision? How have treatment strategies changed over time? The study will provide information on where these patients have been treated in the Region Västra Götaland. During the study period, ESD was introduced as a treatment modality, and it will investigated how this may have influenced treatment strategies for complex adenomas. Clinical outcome measures will include recurrence rates and re-intervention rates for the respective treatments. Possible areas of improvement will be identified and determine if evidence based and best practice guidelines are met with the current treatment strategies in Region Västra Götaland.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Rectal cancer resected by local resection

排除标准

  • All other types of resection or treatment for rectal cancer

结局指标

主要结局

Pathological clear margins

时间窗: 1-2 months after surgery

Pathological examination of the specimen showing free margins

Complications after surgery

时间窗: 90 days after surgery

Complications graded using the Clavien Dindo classification

次要结局

未报告次要终点

研究者

发起方
Sahlgrenska University Hospital, Sweden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eva Angenete

Professor

Sahlgrenska University Hospital, Sweden

研究点 (1)

Loading locations...

相似试验

TRECA - TREatment of Colorectal Adenomas and Early... | 临床试验